You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
Dermatology

Targeted Therapies for Children With Atopic Dermatitis - Expert Interview

Dermatologist Elaine Seigfried discusses burden & therapeutic landscape of pediatric atopic dermatitis

Elaine Siegfried
MD
Elaine Siegfried

Learning objectives

  • Examine the challenges faced by dermatologists when managing moderate-to-severe atopic dermatitis in children (<12 years)
  • Explore the relevance of targeting type 2 inflammation and the implications for disease course modification in childhood
  • Review emerging data on treatment options and practical management of children with moderate-to-severe atopic dermatitis

Description

In the ADVENT symposium at the 2023 World Congress of Dermatology, entitled “Atopic Dermatitis (AD) in Children: Early Intervention Can Reduce Long-term Disease Impact” experts Amy Paller, MD (Northwestern University, USA), Mark Koh, MD (KK Women’s & Children’s Hospital, Singapore), Stephan Weidinger, MD, PhD (Christian-Albrecht University, Kiel, Germany) and Elaine Siegfried, MD (Saint Louis University School of Medicine, USA), delved into the challenges and advancements in the management of moderate-to-severe atopic dermatitis in pediatric patients. The presentations emphasized the significance of targeting type 2 inflammation, explored implications for disease course modification during childhood, and provided insights into emerging treatment options and practical management strategies for children with moderate-to-severe atopic dermatitis.

MAT-GLB-2303394 V2 07/2023

About this expert

Dermatology

Elaine Siegfried

MD

Professor of Pediatrics and Dermatology in the Department of Pediatrics, Division of Dermatology at Saint Louis University School of Medicine, US

See author’s profile
Elaine Siegfried

Related resources